NEW YORK ( TheStreet) -- Biosante Pharmaceuticals (Nasdaq: BPAX) is trading at unusually high volume Wednesday with 7.4 million shares changing hands. It is currently at 4.3 times its average daily volume and trading down 39 cents (-15.5%) at $2.13 as of 4 p.m. ET. Biosante has a market cap of $278.4 million and is part of the health care sector and drugs industry. Shares are up 49.4% year to date as of the close of trading on Tuesday. BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, develops products for female sexual health and oncology. TheStreet Ratings rates Biosante as a sell. Among the areas we feel are negative, one of the most important has been weak operating cash flow. You can view the full Biosante Ratings Report. See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center. Interested in other stocks that are falling on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting HVDOWN to 95370 or select from multiple alert options.
More from Markets
WeWork's Quarterly Loss Balloons as Costs Soar, IPO Plans Fail
Office space sharing company WeWork lost $1.25 billion in the third quarter, ahead of a bailout last month by Japan's SoftBank Group.
Dow, S&P 500 End at Record Highs; Disney+ Subscriptions Surge
The Dow Jones Industrial Average and the S&P 500 close at record highs Wednesday, propelled by a surge in Disney+ subscriptions.
The Market May Be At All-Time Highs, but Be Wary of Divergences
Let's take a close look at the market.
Investors: Don't Expect a Rate Cut for the Holidays
The Fed has only nine rate cuts to use, has used three, and must deploy the rest judiciously. Plus, the federal deficit makes cutting rates hard right now.